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FATTY ACIDS SERVE AS THE PRIMARY energy substrate for the contracting heart via their oxidation in the mitochondria. Oxidation of fatty acids in the heart may be altered during specific disease conditions impacting the heart, including cardiac failure, myocardial ischemia, and diabetes (23) . Impaired oxidation or excess delivery of fatty acids in the heart may give rise to cardiomyocellular lipid storage. Limited variation in cardiac lipid storage can be considered normal and occurs as a direct consequence of physiological fluctuations in circulating free fatty acids (35) . However, chronically elevated cardiac lipid storage is considered harmful and may lead to lipotoxic cardiomyopathy (24) .
Fatty acids entering the cardiomyocyte can originate from two principal sources, which are circulating triglyceride (TG)-rich lipoproteins and circulating albumin-bound free fatty acids. The former pathway, shown to be the main source of fatty acids for the heart (3, 31) , requires the catalytic activity of lipoprotein lipase (LPL), which is anchored into the capillary endothelium. To what extent fatty acids from different extracellular sources are channeled into different intracellular pathways in the heart remains to be investigated.
While most of the fatty acids entering the cardiomyocyte are oxidized, a small portion of the incoming fatty acids are transported toward the nucleus and alter gene transcription to modulate cardiometabolic functions. Several transcription factors are implicated in mediating effect of fatty acids on gene transcription in various tissues, including sterol regulatory element binding protein-1c, hepatocyte nuclear factor 4␣, and peroxisome proliferator-activated receptors (PPARs) (25) . PPARs are ligand-activated transcription factors that govern DNA transcription by direct binding to promoters of target genes (16) . In addition, they downregulate gene expression by interfering with the activity of other transcription factors. The family of PPARs consists of three members encoded by distinct genes: ␣, ␦, and ␥, which are each characterized by specific tissue and developmental patterns of expression.
PPAR␣ serves as the molecular target for the fibrate class of drugs. In addition, PPAR␣ is activated by fatty acids and various fatty acid derivatives such as eicosanoids and endocannabinoids. In vitro studies show that PPAR␣ has a preference towards long-chain polyunsaturated fatty acids (PUFAs) (12, 18, 19) . While several studies have examined the effect of fatty acids on PPAR target genes in isolated cardiomyocytes, showing induction of typical PPAR␣ targets such as Ucp2, Cpt1a, Cd36, Fabp3, Acsl1, Acot1, and Acadl (5, 10, 32, 34) , little is known about gene regulation by fatty acids in the intact heart.
Previously, we described an in vivo model that allows characterization of the transcriptional targets of PUFAs in diverse tissues in vivo (14, 26) . In this model, mice are given a single oral bolus of synthetic triglycerides composed of a single fatty acid. We showed that the Angptl4 gene is a very sensitive target of fatty acids in the heart and furthermore that its upregulation is part of a protective mechanism against cardiac lipotoxicity (14) . The present study examines the whole genome effects of individual dietary fatty acids in the heart via transcriptional profiling. By conducting these experiments in wild-type and PPAR␣Ϫ/Ϫ mice, the specific contribution of PPAR␣ could be determined.
METHODS

Chemicals.
Wy14643 was obtained from Eagle Picher Technologies laboratories (Lenexa, KS). Triolein, trilinolein, trilinolenin, and tridocosahexaenoin were from Nu-Chek-Prep (Elysian, MN). Cell culture media, fetal bovine serum, and penicillin-streptomycin were from Lonza (Verviers, Belgium).
Animals and oral lipid load. Pure-bred Sv129 and PPAR␣Ϫ/Ϫ mice (2-6 mo of age) on a Sv129 background were used. In the short-term experiment, animals were switched to a run-in diet consisting of a modified AIN76A diet (corn oil was replaced with olive oil to minimize baseline intake of PUFAs, which are more potent activators of PPAR␣), 2 wk before the start of the experiment (Research Diet Services, Wijk bij Duurstede, the Netherlands). Starting at 5:00 AM the animals were fasted for 4 h followed by an intragastric gavage of 400 l synthetic triolein, trilinolein, trilinolenin, or tridocosahexaenoin. Wy14643 was given as 400 l of a 10 mg/ml suspension in 0.5% carboxylmethyl cellulose. The latter also served as control treatment (400 l). Six hours after the oral gavage the mice were anesthetized with a mixture of isoflurane (1.5%), nitrous oxide (70%), and oxygen (30%). Blood was collected by orbital puncture, followed by death of the mice by cervical dislocation. Hearts were removed, snap-frozen in liquid nitrogen, and stored at Ϫ80°C.
In the long-term experiment, wild-type and PPAR␣Ϫ/Ϫ mice were fed a chow diet (RMH-B diet, Arie Blok, Woerden, the Netherlands) containing 0.1% Wy14643 for 5 days. The animal experiments were approved by the animal ethics committee of Wageningen University.
Microarray analysis. RNA from total heart was extracted with TRIzol reagent and purified using RNeasy Mini kit (Qiagen, Venlo, Netherlands). RNA quality was assessed on an Agilent 2100 Bioanalyzer (Agilent Technologies, Amsterdam, the Netherlands) with 6,000 Nano Chips using a Eukaryote Total RNA Nano assay. Expression profiling was carried out on individual mouse hearts using Affymetrix Mouse Genome 430 2.0 Arrays (short term experiment) or on pooled RNA from four or five mice using Affymetrix Mouse NuGO arrays (long-term experiment). Hybridization, washing and scanning of the arrays were done according to standard Affymetrix protocols. Scans of the Affymetrix arrays were processed using packages from the Bioconductor project (13) . Raw signal intensities were normalized by using the GCRMA algorithm (36) . Probe-sets were defined according to Dai et al. (8) using remapped CDF version 11.0.2 based on the Entrez gene database. The Bioconductor R package linear models for microarray data (LIMMA) was used to identify differentially expressed genes. All comparisons were simultaneously analyzed. To balance between random responses and relative weak transcriptional effects by the treatments, genes that met the cut-off of mean absolute fold change Ͼ1.2 and P value Ͻ0.01 were considered significantly regulated. A regularized t-test was used, which has the same interpretation as an ordinary t-test except that the standard errors have been moderated across genes, i.e., shrunk to a common value, using a Bayesian model (30) . The microarray datasets have been submitted to the National Center for Biotechnology Information's Gene Expression Omnibus (GSE30495 and GSE30553).
Functional classification of genes. For functional classification of probe-sets/genes into gene sets clusters or biological pathways, Gene Set Enrichment Analysis (GSEA) and Ingenuity software v.6.5 were used. For identifying specific pathways regulated by each treatment we used Ingenuity canonical pathways, considering only differentially expressed genes with a P value Ͻ0.01 (fatty acids and Wy14643 treatment) or differentially expressed genes with a P value Ͻ0.01 and fold-change Ͼ1.2 (baseline wild type vs. PPAR␣Ϫ/Ϫ). For GSEA differentially expressed gene sets with a P value Ͻ0.05 were considered.
Correlation plot. Signal log ratios were calculated between intensity values for individual animals and the mean intensity value of the wild-type control group. Signal log ratios of genes significantly regulated by at least one treatment were used as input for a correlation plot in Biowisdom Omniviz 6.0.3 (Cambridge, UK).
RESULTS
Oral feeding of synthetic TGs.
To study the effect of individual fatty acids on in vivo gene expression in the heart, mice fasted for 4 h were given a single oral dose (400 l) of synthetic TGs consisting of one single fatty acid, followed by collection of the heart 6 h thereafter (26) . The dosage mirrors the amount of dietary fat provided in a postprandial lipid test in humans. The fatty acids studied were oleic acid (C18:1), linoleic acid (C18:2), linolenic acid (C18:3), and docosahexaenoic acid (C22:6). In addition, a set of mice was given a single oral dose of the synthetic PPAR␣ agonist Wy14643. No saturated fatty acids were included because TGs composed of common dietary saturated fatty acids are solid at room temperature and could not be administered orally. The 6 h time point was chosen because dietary TGs enter into the circulation within 1 h after intake and a constant rate of absorption is sustained for at least 4 h thereafter (Fig. 1A) . The focus of the present study is on heart since heart shows the highest relative rate of uptake of dietary fatty acids, when expressed per gram organ weight (31) . No major differences in metabolic processing of dietary fat between wild-type and PPAR␣Ϫ/Ϫ mice and between different dietary fatty acids were observed in this study (26) .
Similarity in gene regulation between fatty acids. Expression profiling carried out on individual mouse hearts indicated that the largest number of genes was changed following treatment with C18:3, followed by C22:6, C18:2, Wy14643, and finally C18:1 (Fig. 1B) . The proportion of genes up-and downregulated was approximately equal and was consistent throughout the various treatments. C22:6 showed the most pronounced overlap in gene regulation with Wy14643, followed by C18:3, C18:2, and C18:1 (Fig. 1C) . Next we studied the similarity in gene regulation between the various fatty acids via scatter plot analysis, in which the mean fold-change in expression of a gene by one treatment is expressed in one dimension, and the mean fold-change in expression of the same gene by another treatment is expressed in the other dimension. Results indicate that mean changes in gene expression elicited by C18:3 and C18:2 were highly similar ( Fig. 2A) , as illustrated by the limited scatter. Much less similarity in gene regulation was observed between C18:2 (or C18:3) and C22:6. Consistent with the above data, Wy14643 showed the least scatter, indicating highest similarity, when plotted against C22:6, compared with the other fatty acids. Similar results were obtained via correlation analysis, which determines the magnitude of correlation in overall gene expression between two individual mice (Fig. 2B ). High correlation in gene expression was observed between mice that received C18:2 and mice that received C18:3. Compared with C22:6, mice that received C18:2 or C18:3 correlated relatively poorly with mice given Wy14643.
To compare the effects of the various treatments, we determined the top 10 of genes most significantly up-or downregulated by each treatment ( Table 1) . Some of the top upregulated genes were regulated by all five treatments (Zbtb16/PLZF) or by four treatments (Hmox1, Angptl4, Ucp3). Many of the commonly upregulated genes are involved in metabolic pathways (Hmgcs2, Acot1, Angptl4) or oxidative stress (Hmox1, Ucp3, Mt2). Genes that were consistently downregulated by Wy14643 and fatty acids included the nuclear receptor Nurr1 (Nr4a1) and fibroblast growth factor 16 (Fgf16). To illustrate specific patterns of gene regulation, examples of genes that were regulated by all treatments, by all fatty acids, or by only one treatment are shown in Fig. 3A . Only a small proportion of the genes were regulated by all five treatments or by all fatty acids (Fig. 3B ). Many more genes were either exclusively regulated by one particular treatment (Fig. 3B) or shared between two treatments (data not shown).
We next investigated whether similarities in gene regulation between the various treatments were also observed at the level of pathways. To that end, Ingenuity pathway analysis was carried out on the changes in gene expression caused by each treatment. The results reveal that many pathways are commonly regulated by the various fatty acids, including several pathways related to metabolism of amino acids and fatty acids ( Table 2 ). The number of pathways specifically regulated by one fatty acid was limited, with the exception of C22:6, which specifically regulated several pathways related to inflammation and cytokine/growth factor signaling. Similar data were obtained by GSEA (Fig. 3C) . Most of the gene sets enriched among genes upregulated by the various treatments were related to nutrient/energy metabolism, except for C22:6, which induced gene sets involved in a variety of biological functions. The special status of C22:6 was not evident among downregulated gene sets. These data indicate that C22:6 induces the most diverse biological response in cardiac gene expression compared with the other fatty acids studied.
Role of PPAR␣ in gene regulation by fatty acids. Several of the top regulated genes by fatty acids are target genes of PPAR␣ (Table 1 ). In addition, significant overlap was observed between gene regulation by fatty acids and Wy14643 (Figs. 1C and 2A) . These results suggest that PPAR␣ plays a role in gene regulation by dietary fatty acids in heart in vivo. To better define the role of PPAR␣ in heart, we first determined the impact of PPAR␣ deletion on basal whole genome gene expression in the heart using PPAR␣Ϫ/Ϫ mice. Using a cut-off of fold-change Ͼ1.2 and P Ͻ 0.01, we found that 294 genes showed elevated expression and 297 genes showed reduced expression in PPAR␣Ϫ/Ϫ mice (Fig. 4A) . Many of the top downregulated genes represented known targets of PPAR␣ involved in lipid metabolism, including Acot1, Acot2, Ucp3, Gpam, and Slc22a5 (Fig. 4B) . The functional roles of the top upregulated genes in PPAR␣Ϫ/Ϫ mice was more diverse, including genes involved in lipid metabolism (Acsl6, Angptl4) but also genes involved in immune response, cell cycle, and oxidative stress response. Pathways differentially expressed between wild-type and PPAR␣Ϫ/Ϫ mice according to Ingenuity pathways analysis fell into four main categories: lipid metabolism, amino acid metabolism, carbohydrate metabolism, and inflammation/immunity, reflecting the established role of PPAR␣ in these processes (Fig. 4C) .
We next set out to investigate the importance of PPAR␣ in gene regulation by dietary fatty acids in the heart. Regulation of a particular gene by dietary fatty acids or synthetic agonists was defined as PPAR␣-dependent when expression was statistically significantly up-or downregulated in wild-type but not PPAR␣Ϫ/Ϫ mice. As expected given the high specificity of the Wy14643 compound, gene regulation by Wy14643 was almost completely dependent on PPAR␣, which was equally observed for up-or downregulated genes (Fig. 5, A and B) . The importance of PPAR␣ in gene regulation by dietary fatty acids was less pronounced but still remarkably high. Interestingly, a very uniform picture was observed for the three PUFAs studied. Specific examples of genes showing clear PPAR␣-dependent or -independent gene regulation by dietary fatty acids are shown in Fig. 5C . Induction of Ucp3 and Acot1 expression by Wy14643 and fatty acids was entirely dependent on PPAR␣, whereas induction of Zbtb16/ PLZF was completely independent of PPAR␣. Expression of Pdk4 and Hmox1 showed a mixed picture: Whereas induction by Wy14643 was entirely PPAR␣-dependent, this was not or only partially observed for the various fatty acids. Taken together, these data indicate that PPAR␣ plays a major role in gene regulation by dietary fatty acids in heart, although other mechanisms contribute as well.
Role of PPAR␣ in cardiac gene regulation. As mentioned above, gene regulation by Wy14643 in heart was entirely mediated by PPAR␣. To further understand the impact of PPAR␣ on cardiac gene regulation, we carefully analyzed the whole genome effects of short-term or long-term administration of Wy14643, focusing on metabolism-and immunityrelated genes. Genes were classified according to 1) differential expression in PPAR␣Ϫ/Ϫ mice in the absence of Wy14643, 2) induction after short-term Wy14643 treatment, 3) induction after long-term Wy14643 treatment. A limited number of metabolic genes were regulated in all three conditions, representing robust PPAR␣ targets such as Ucp3, Hmgcs2, Acot1, and Ehhadh (Supplemental Table S1 ). 1 Interestingly, many genes classified as PPAR␣ targets based on literature were not induced by Wy14643, even though their expression was decreased in the PPAR␣Ϫ/Ϫ mice. Conversely, a considerable number of genes were induced by Wy14643 but were unaltered in the PPAR␣Ϫ/Ϫ mice at baseline. The former could be classified as baseline PPAR␣ targets, whereas the latter may be classified as inducible targets.
A large number of genes altered by PPAR␣ deletion or by Wy14643 was related to inflammation and immunity (Supplemental Table S2 ). Although the maximal magnitude of foldchange of inflammation/immunity-related genes was less compared with metabolism-related genes, the number of genes altered was at least as high, demonstrating the impact of PPAR␣ on inflammation and immunity in heart. One gene that was robustly regulated by PPAR␣ in all three conditions was Serpine1, also known as plasminogen activator inhibitor-1. A complete list of genes can be found in Supplemental Table S1 .
DISCUSSION
In this study we set out to study the impact of individual dietary unsaturated fatty acids on whole genome gene regulation in the intact mouse heart and assess the role of PPAR␣. Our findings can be summarized as follows: 1) C18:3 had the most pronounced effect on cardiac gene expression.
2) The largest overall similarity in gene regulation was observed between C18:2 and C18:3, which was equally true for genes regulated in a PPAR␣-dependent and -independent manner. The synthetic PPAR␣ agonist Wy14643 and C22:6 also showed marked similarity in gene regulation. 3) Many genes were regulated by one particular treatment only. Genes regulated by one particular treatment showed large functional divergence. 4) The majority of genes responding to fatty acid treatment were regulated in a PPAR␣-dependent manner, emphasizing the importance of PPAR␣ in mediating transcriptional regulation by fatty acids in the heart. 5) Several genes were robustly regulated by all or many of the fatty acids studied. A number of these genes are well-described targets of PPARs whereas others seem to be regulated via a different mechanism.
Dietary fatty acids enter the circulation packaged in TG-rich chylomicron particles and enter the heart after lipolytic processing by lipoprotein lipase. The importance of hydrolysis of TG-rich lipoproteins for generating endogenous ligands for cardiac PPAR␣ has been recognized (9, 37) . Our data extend these previous findings and show that dietary fatty acids cause marked induction of several PPAR␣ target genes. In addition, it is shown that dietary fatty acids, and therefore the lipolysis pathway, also lead to gene regulation via other signaling routes. Part of the PPAR␣-independent regulation may occur via PPAR␦ (e.g., Pdk4, Angptl4), but other mediators are likely also involved, including Nrf (nuclear factor erythroid 2-related factor)2. Nrf2 is a transcription factor that is activated by unsaturated fatty acids after their conversion to electrophilic oxo or nitro derivatives and stimulates antioxidant gene regulation (15) . An important property of PUFAs is that they not only serve as metabolic substrates but also are sources of lipotoxic derivatives, such as lipid peroxides and reactive oxygen species as secondary products of fatty acid oxidation. Thus, the effects of (dietary) PUFA on expression of genes involved in the oxidative stress response are likely mediated by specific fatty acid oxidation products via NRF2-dependent signaling. Activation of Nrf2 may explain why a large Genes regulated by Ͼ1 treatment are shown in boldface. FC, fold-change. Fig. 3 . Fatty acid specific gene regulation in mouse heart. A: changes in expression of selected genes in wild-type mice by the different treatments, illustratingnumber of genes induced by dietary unsaturated fatty acids are involved in oxidative stress response. Recent data point to cross talk between regulation of lipid metabolism and the oxidative stress response. It was found that the antioxidant transcription factor Nrf2, besides governing oxidative stress target genes, also alters expression of numerous genes involved in lipid metabolism (17) . Conversely, PPARs, which have a primary function in lipid metabolism, directly regulate expression of a number of oxidative stress genes, exemplified by Hmox1 (1, 20, 21) . One surprising gene that was markedly and consistently induced by all fatty acids was Zbtb16/PLZF, encoding a transcription factor that controls the development of effector functions in natural killer T (NKT) cells (2) . NKT cells represent an unique subset of lymphocytes that are reactive to so-called lipid antigens, which include a broad range of microbial lipids that are unique structures of specific microorganisms. Based on its sensitive regulation by fatty acids, one could speculate whether Zbtb16/PLZF may link dietary lipids to NKT cell function.
Previously, we studied the impact of dietary fatty acids on gene expression in the liver under the same experimental settings (26) . When expressed per gram organ weight, the liver and heart both exhibit very high and very similar rates of fatty acid uptake from TG-rich lipoproteins (26) . Remarkably, the percentage of genes regulated by fatty acids independently of PPAR␣ is considerably higher in heart compared with liver. Additionally, the panel and functional categories of genes regulated by fatty acids in the liver mostly reflect regulation of lipid metabolism, which is less the case in heart. Furthermore, relative inductions of PPAR␣ target genes by dietary fatty acids are less pronounced in heart. Together, these data clearly demonstrate a less dominant role of PPAR␣ in cardiac gene regulation by dietary fatty acids compared with the liver. Apart from differences in PPAR␣ expression level between heart and liver, this finding may be related to differences in the route of uptake of fatty acids between the two tissues in the postprandial state. Whereas the heart takes up dietary fatty acids as nonesterified fatty acids after LPL-mediated hydrolysis, the liver internalizes dietary fatty acids as TG within chylomicron remnant particles (3, 31) . The ability of fatty acids to directly activate PPAR␣ may depend on the form in which they are presented to the cell (7, 27) . Free fatty acids may need to be converted to TG and undergo subsequent hydrolysis before they can activate PPAR␣. Alternatively, it is possible that within the heart fatty acids are more efficiently shuttled toward oxidative pathways to meet the high energetic demands of the contracting heart.
It can be argued that direct comparison of the various fatty acid treatments requires comparable levels of cardiac uptake of the different fatty acids. Unfortunately, the unavailability of radioactive TGs except triolein makes it impossible to get precise information on the kinetic behavior of the fatty acids used. Our previous study did not reveal major differences in metabolic processing of dietary fat between wild-type and PPAR␣Ϫ/Ϫ mice and between different dietary fatty acids (26) . Even if one assumes some differences in kinetic behavior between the fatty acids used, these are unlikely to account for the major qualitative differences in gene regulation between the fatty acids studied. It is difficult to compare our results directly with in vitro data. Lockridge and colleagues (22) performed microarray analysis on isolated cardiomyocytes treated with various fatty acids. Remarkably, the number of genes altered by saturated fatty acids was much higher compared with unsaturated fatty acids. One of the limitations of this study is that we were unable to investigate the effects of saturated fatty acids, as TGs composed of saturated fatty acids are solid at body temperature.
Differential gene regulation by the various fatty acids via PPAR␣ may be hypothesized to occur via the selective PPAR modulator concept, in which different PPAR␣ ligands may not only give rise to quantitative differences but also cause qualitative differences in gene regulation due to the differential recruitment and release of coactivators and co-repressors, respectively. While we previously found support for differential coactivator recruitment between Wy14643 and DHA, no differences were found between various fatty acids (26) .
Most of our understanding of the role of cardiac PPAR␣ is based on studies of transgenic mice overexpressing PPAR␣ in the heart. These mice are characterized by marked induction of genes involved in cardiac fat oxidation but also fatty acid uptake, resulting in cardiac lipid accumulation and subsequent cardiomyopathy (4, 6, 11). A few genes within these pathways have been identified as direct targets of PPAR␣ in heart. Our Intrinsic prothrombin activation pathway data underscore the importance of PPAR␣ in lipid metabolism in the heart and reveal a large resemblance between the PPAR␣ transcriptome in heart and liver. Similar to the dietary fatty acids, Wy14643 was surprisingly much less potent in inducing gene expression in heart compared with liver. A possible explanation is that Wy14643 is taken up more poorly by the heart, although no actual data are available to support this notion. Deletion of PPAR␣ had a marked effect on cardiac gene regulation after a 10 h fast, representing the baseline condition, which suggests that 1) PPAR␣ has a high constitutive activity, or 2) PPAR␣ is already mostly ligand activated after a 10 h fast Fig. 4 . Effect of PPAR␣ deletion on gene expression in mouse heart. A: number of genes upregulated or downregulated in PPAR␣Ϫ/Ϫ mice compared with wild-type mice at baseline (control treatment, carboxymethylcellulose) according to P Ͻ 0.01 and mean fold change Ͼ1.2. B: heat map showing changes in expression of the 20 genes exhibiting the highest mean fold increase (top) and decrease (bottom) in PPAR␣Ϫ/Ϫ mice compared with wild-type mice at baseline. Each column represents one individual mouse. Mean fold change of wild-type mice was set at 1.0. C: Ingenuity canonical pathway analysis of changes in gene expression between wild-type and PPAR␣Ϫ/Ϫ mice at baseline. Line reflects Ϫlog(P value). The colored bars reflect the percentage of genes within a particular pathway that was downregulated (green bar), upregulated (red bar), or absent from the dataset (white bars). (33) , which would be consistent with the high rate of fatty acid uptake under those conditions. Although expression of numerous genes involved in lipid metabolism was markedly reduced in PPAR␣Ϫ/Ϫ mice, this does not result in cardiac dysfunction, at least in the absence of an additional stressor (28) .
Apart from metabolism related genes, many genes involved in inflammation/immunity were altered upon PPAR␣ deletion. Our findings are supported by recent studies describing differential expression of immunity and cellular defense related genes in hearts of PPAR␣Ϫ/Ϫ mice compared with wild-type mice (28, 29) . Many of those genes are regulated via NF-B, pointing towards transrepression by PPAR␣. This anti-inflammatory effect of PPAR␣ may be especially relevant in the context of cardiac hypertrophy, which is characterized by induction of inflammatory pathways.
In conclusion, our study provides the first comprehensive analysis of the acute effects of dietary fatty acids on gene expression in the heart. The data demonstrate the importance of PPAR␣ in mediating gene regulation by dietary fatty acids in the heart.
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